Market Value2,078,351,000
Total Holdings55
File Date2013-11-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ARAY / Accuray Incorporated
US00448Q2012 / Achillion Pharmaceuticals, Inc.
018490100 / Allergan plc
AKRX / Akorn, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
ALGN / Align Technology, Inc.
018490100 / Allergan plc
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
ILMN / Illumina, Inc.
MRK / Merck & Co., Inc.
PFE / Pfizer Inc.
OMED / OptMed Inc
ARIA / ARIAD Pharmaceuticals, Inc.
BIIB / Biogen Inc.
SHPG / Shire Plc.
HTWR / Heartware International Inc.
CELG / Celgene Corp.
CLDX / Celldex Therapeutics, Inc.
CLVS / Clovis Oncology Inc
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
HALO / Halozyme Therapeutics, Inc.
DXCM / DexCom, Inc.
INSM / Insmed Incorporated
EVAC / EQV Ventures Acquisition Corp. II
345838106 / Forest Laboratories Inc
HOLX / Hologic, Inc.
IMGN / ImmunoGen, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
IRWD / Ironwood Pharmaceuticals, Inc.
US00C4U1L353 / Mylan N.V.
MDVN / Medivation, Inc.
US60877T1007 / Momenta Pharmaceuticals, Inc.
NPSP / NPS Pharmaceuticals Inc
TMO / Thermo Fisher Scientific Inc.
NVS / Novartis AG - Depositary Receipt (Common Stock)
ONXX / Onyx Pharmaceuticals Inc
PRGO / Perrigo Company plc
PCYC / Pharmacyclics
0PP / Portola Pharmaceuticals Inc
NXTM / NxStage Medical, Inc.
SQNM / Sequenom, Inc.
GEVA / Synageva Biopharma Corp
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
INVA / Innoviva, Inc.
885175307 / Thoratec
US92220P1057 / Varian Medical Systems, Inc.
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
UTHR / United Therapeutics Corporation
VIROPHARMA INC / (928241108)
LLY / Eli Lilly and Company
COV /
MNKKQ / Mallinckrodt Plc
IONS / Ionis Pharmaceuticals, Inc.
WMGIZ / Wright Medical Group N.V.
AMGN / Amgen Inc.
PTCT / PTC Therapeutics, Inc.
SGEN / Seagen Inc
SGNT / Sagent Pharmaceuticals, Inc.
INCY / Incyte Corporation
BMRN / BioMarin Pharmaceutical Inc.
VRTX / Vertex Pharmaceuticals Incorporated
GILD / Gilead Sciences, Inc.
EW / Edwards Lifesciences Corporation
BSX / Boston Scientific Corporation